Related Experiment Videos
Interleukin-1 and inflammatory neurodegeneration.
1Department of Neuroscience, Division of Molecular Neurobiology, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Biochemical Society Transactions
|October 25, 2007
Summary
Inflammation, driven by interleukin-1 (IL-1), significantly worsens brain injury after stroke or trauma. The IL-1 receptor antagonist (IL-1RA) shows promise in reducing this damage and aiding recovery in stroke patients.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Inflammation is a rapid response to acute brain insults like stroke, hemorrhage, and trauma.
- Chronic inflammatory conditions such as Alzheimer's, Parkinson's, and multiple sclerosis also involve sustained inflammation.
- The cytokine interleukin-1 (IL-1) is a key mediator in neurodegeneration, predominantly released by microglia upon neuronal injury.
Purpose of the Study:
- To elucidate the mechanisms of IL-1 expression, release, and action in neurodegeneration.
- To investigate the role of IL-1 in exacerbating brain injury.
- To evaluate the therapeutic potential of IL-1 receptor antagonist (IL-1RA) in brain injury models and clinical settings.
Main Methods:
- Review of experimental evidence on inflammation and neurodegeneration.
- Analysis of IL-1's role in mediating brain injury, including its effects on neutrophils and matrix metalloproteinase-9.
- Assessment of IL-1RA's efficacy in preclinical models (rodents) and clinical trials (stroke patients).
Main Results:
- Elevated IL-1 levels markedly exacerbate brain injury.
- Systemic IL-1 enhances ischemic brain injury through neutrophil activation and CNS invasion.
- IL-1RA demonstrates significant inhibition of ischemic, excitotoxic, and traumatic brain injury in rodents.
- IL-1RA has shown promise in a Phase II clinical trial for stroke patients, entering the CNS peripherally without adverse effects.
Conclusions:
- Interleukin-1 (IL-1) is a critical mediator in neurodegeneration and exacerbates brain injury.
- IL-1 receptor antagonist (IL-1RA) effectively inhibits various forms of brain injury in preclinical models.
- IL-1RA presents a promising therapeutic strategy for acute brain injury, particularly stroke, with demonstrated safety and potential efficacy in clinical trials.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:38Inflammation
Overview